Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 50751-50800 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05264337
Lymphedema After Urologic Surgery
N/ARecruiting
400 participants
Started: Mar 14, 2022 · Completed: Jan 31, 2030
4 conditions1 sponsor2 locations
NCT05829681
Individualized Neuroimaging Biomarkers for Predicting RTMS Response in OCD
NARecruiting
360 participants
Started: Mar 14, 2022 · Completed: Mar 14, 2029
1 condition3 sponsors1 location
NCT05236582
Herombopag for Chemotherapy-induced Thrombocytopenia
PHASE2Recruiting
50 participants
Started: Mar 14, 2022 · Completed: Dec 31, 2025
2 conditions7 sponsors1 location
NCT05103033
Systems Analysis and Improvement Approach to Optimize the Task-shared Mental Health Treatment Cascade (SAIA-MH)
NARecruiting
155 participants
Started: Mar 14, 2022 · Completed: Feb 28, 2026
1 condition4 sponsors16 locations
NCT05522959
Cardio-Oncology Rehabilitation Exercise
N/ARecruiting
100 participants
Started: Mar 14, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05085756
Transdiagnostic Internet Intervention to Improve Mental Health Among University Students
NARecruiting
200 participants
Started: Mar 14, 2022 · Completed: Jun 30, 2027
1 condition5 sponsors1 location
NCT05470088
MRI Study of Subjects with ASD, Their Relatives and TD
N/ARecruiting
1,000 participants
Started: Mar 13, 2022 · Completed: Sep 13, 2039
1 condition4 sponsors2 locations
NCT06001736
Utility of CC7 Transfer in Stroke Subtypes
NARecruiting
95 participants
Started: Mar 13, 2022 · Completed: Mar 1, 2027
3 conditions1 sponsor1 location
NCT04733404
Safety and Effectiveness Study of Dragonfly System for Functional Mitral Regurgitation
NARecruiting
120 participants
Started: Mar 12, 2022 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT05244486
Efficacy of RestoreX Penile Traction Therapy In Preserving Erectile Function Post-Prostatectomy
NARecruiting
200 participants
Started: Mar 12, 2022 · Completed: Sep 14, 2030
1 condition1 sponsor1 location
NCT05082519
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
PHASE2Recruiting
240 participants
Started: Mar 12, 2022 · Completed: Oct 15, 2031
2 conditions2 sponsors20 locations
NCT05168618
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
PHASE2Recruiting
33 participants
Started: Mar 11, 2022 · Completed: Jan 31, 2027
5 conditions2 sponsors1 location
NCT05899920
Clinical One-stage Controlled Study of reSistant Arterial Hypertension for the desiGning of a personAlized Approach to Therapy
NARecruiting
190 participants
Started: Mar 11, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06643650
Study to Document the Phenomenon of Vitamin D Deficiency and Its Added Value in Patients with Low-energy Osteoporotic Hip Fracture, in Daily Practice in Greece.
N/ARecruiting
30 participants
Started: Mar 11, 2022 · Completed: May 31, 2025
4 conditions1 sponsor1 location
NCT04496479
Allogenic Hepatocyte Transplantation Into Periduodenal Lymph Nodes
PHASE2Recruiting
12 participants
Started: Mar 11, 2022 · Completed: Dec 30, 2027
1 condition1 sponsor2 locations
NCT05121025
Pathogen-microbiome Interaction During Helicobacter Pylori Infection
N/ARecruiting
180 participants
Started: Mar 11, 2022 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT01297400
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
PHASE2Recruiting
60 participants
Started: Mar 11, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor5 locations
NCT05247268
Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer
PHASE2Recruiting
104 participants
Started: Mar 11, 2022 · Completed: Sep 10, 2027
1 condition2 sponsors1 location
NCT05351099
Dental Block for Pain Relief in ED Dental Pain Patients
N/ARecruiting
195 participants
Started: Mar 11, 2022 · Completed: Mar 11, 2026
1 condition1 sponsor1 location
NCT05964439
Augmented Reality Ultrasound Guidance
NARecruiting
44 participants
Started: Mar 11, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05182229
Comparing Two Ways to Manage Head and Neck Lymphedema
NARecruiting
300 participants
Started: Mar 11, 2022 · Completed: Nov 30, 2026
2 conditions2 sponsors6 locations
NCT04864054
T-Cell Therapy (ECT204) in Adults With Advanced HCC
PHASE2Recruiting
20 participants
Started: Mar 11, 2022 · Completed: Dec 31, 2027
4 conditions1 sponsor5 locations
NCT05360212
Anatomy-based Fitting in Cochear Implant Users
NARecruiting
30 participants
Started: Mar 11, 2022 · Completed: Dec 31, 2026
3 conditions2 sponsors1 location
NCT05699083
Outcomes After Weight Loss Surgery in Low-Risk Patients
NARecruiting
20 participants
Started: Mar 11, 2022 · Completed: Jan 12, 2026
2 conditions1 sponsor1 location
NCT05138614
Supporting Treatment Access and Recovery in COD
NARecruiting
1,000 participants
Started: Mar 11, 2022 · Completed: Aug 31, 2026
2 conditions5 sponsors5 locations
NCT04852744
NEUROIMAGING OF ADOLESCENT BORDERLINE PERSONALITY DISORDER WITH AND WITHOUT POST-TRAUMATIC STRESS DISORDER
NARecruiting
99 participants
Started: Mar 11, 2022 · Completed: Jun 1, 2028
1 condition7 sponsors1 location
NCT05193591
Anti-C1s, Anti-HMGB1 and Anti-C1q Autoantibodies in Systemic Lupus Erythematosus (DYSALARM-322)
N/ARecruiting
30 participants
Started: Mar 11, 2022 · Completed: Sep 10, 2025
1 condition2 sponsors2 locations
NCT05241457
Achieving Meaningful Clinical Benchmarks With Ekso Gait Training During Acute Stroke Inpatient Rehabilitation.
N/ARecruiting
120 participants
Started: Mar 11, 2022 · Completed: Mar 31, 2026
4 conditions1 sponsor1 location
NCT05315791
Clinical Application Strategies of Maxillary Sinus Buccal Bony Window
NARecruiting
60 participants
Started: Mar 10, 2022 · Completed: Dec 31, 2032
2 conditions1 sponsor1 location
NCT05284877
The Organ Transplant Recipient HPV and Skin Cancer Study
N/ARecruiting
1,500 participants
Started: Mar 10, 2022 · Completed: Mar 31, 2043
7 conditions6 sponsors3 locations
NCT05557123
Mobile App for Improving Adherence of Rivoxaban (RIVOX-AF)
NARecruiting
1,042 participants
Started: Mar 10, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05791916
Novel Biomarkers in Patients With Acute Myocardial Infarction
N/ARecruiting
500 participants
Started: Mar 10, 2022 · Completed: Feb 28, 2025
4 conditions1 sponsor2 locations
NCT05321225
The Level of Blood Brain Barrier Damage Biomarker in Acute Ischemic Stroke
N/ARecruiting
1,000 participants
Started: Mar 10, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05100862
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma
PHASE3Recruiting
780 participants
Started: Mar 10, 2022 · Completed: Jun 30, 2030
2 conditions1 sponsor259 locations
NCT05344443
Lemborexant Shift Work Treatment Study
PHASE4Recruiting
45 participants
Started: Mar 10, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT04530799
Prospective Observational Trial of IAPA
N/ARecruiting
350 participants
Started: Mar 10, 2022 · Completed: Jun 30, 2026
2 conditions1 sponsor12 locations
NCT05621837
Quantifying Systemic Immunosuppression to Personalize Cancer Therapy
N/ARecruiting
1,000 participants
Started: Mar 10, 2022 · Completed: Dec 31, 2026
7 conditions1 sponsor1 location
NCT04805528
Study of Non-invasive Acupuncture-like Transcutaneous Electrical Nerve Stimulation (Altens) to Help Alleviate Xerostomia After Radiation Therapy for Cancers of the Head and Neck
NARecruiting
75 participants
Started: Mar 10, 2022 · Completed: May 31, 2028
1 condition1 sponsor1 location
NCT05468307
Study on TIL Engineered With Membrane-Binding Cytokine for the Treatment of Advanced Gynecologic Tumors
EARLY_PHASE1Recruiting
50 participants
Started: Mar 10, 2022 · Completed: Mar 10, 2025
4 conditions2 sponsors1 location
NCT05315700
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
PHASE1/PHASE2Recruiting
350 participants
Started: Mar 10, 2022 · Completed: Sep 30, 2027
1 condition1 sponsor42 locations
NCT05237375
MIDWIZE - Strengthening Midwives
N/ARecruiting
1,000 participants
Started: Mar 10, 2022 · Completed: Sep 1, 2025
1 condition2 sponsors4 locations
NCT05174169
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
PHASE2/PHASE3Recruiting
1,912 participants
Started: Mar 10, 2022 · Completed: Mar 10, 2030
1 condition3 sponsors1005 locations
NCT05287464
International Multicentric Study ARON-1
N/ARecruiting
1,220 participants
Started: Mar 10, 2022 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT05238883
A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors
PHASE1Recruiting
170 participants
Started: Mar 10, 2022 · Completed: Dec 31, 2026
9 conditions1 sponsor10 locations
NCT05615545
Cryoablation for Advanced Bone and Soft Tissue Tumors
N/ARecruiting
30 participants
Started: Mar 10, 2022 · Completed: Oct 28, 2024
2 conditions1 sponsor1 location
NCT05209763
Standard vs Intensive Rehabilitation and Nutrition Regimen for Inpatients at the ICU
NARecruiting
500 participants
Started: Mar 10, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04927533
The Ronnie Gardiner Method Effectiveness Study
NARecruiting
120 participants
Started: Mar 10, 2022 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT05394714
A Phase I, Autologous ex Vivo Expanded and Activated NK Cell, Magicell-NK, Infusion for Colon Cancer Post Resection Study
PHASE1Recruiting
18 participants
Started: Mar 10, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04711824
Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases
PHASE1/PHASE2Recruiting
41 participants
Started: Mar 9, 2022 · Completed: Nov 30, 2026
2 conditions3 sponsors7 locations
NCT05016609
Same-visit Hepatitis C Testing and Treatment (The QuickStart Study)
PHASE4Recruiting
1,800 participants
Started: Mar 9, 2022 · Completed: Jun 30, 2024
1 condition1 sponsor6 locations